The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHelios Underw Regulatory News (HUW)

Share Price Information for Helios Underw (HUW)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 165.00
Bid: 160.00
Ask: 170.00
Change: 0.00 (0.00%)
Spread: 10.00 (6.25%)
Open: 165.00
High: 165.00
Low: 165.00
Prev. Close: 165.00
HUW Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Reinsurance Agreement

26 Jul 2013 11:21

RNS Number : 2468K
Hampden Underwriting Plc
26 July 2013
 



26 July 2013

 

Hampden Underwriting PLC

("Hampden Underwriting" or the "Company")

 

Reinsurance releases capital for reinvestment in new opportunities

 

Hampden Underwriting, which provides investors with a limited liability direct investment into the Lloyd's insurance market, is pleased to announce the significant release of capital achieved by way of an annually renewable reinsurance arrangement.

 

Overview of the transaction

 

§ Collateralised quota share reinsurance agreement commencing with 2013 year of account

§ 50% of the Company's 2013 insurance exposure ceded to reinsurer

§ Release of £4.1m (approximately 50%) of the Company's £8.2m of Funds at Lloyd's) for reinvestment in new opportunities

§ Ratcheted, performance-based profit commission payable to the Company of between 10% and 20% of the profits arising on business ceded in each period

§ Minimum term of one year renewable annually thereafter

 

 

Commenting upon this transaction Sir Michael Oliver, the Company's Chairman, said:

"This transaction presents Hampden Underwriting with a welcome source of capital with which to fund near-term opportunities the Company wishes to pursue and does so on attractive commercial terms. The Board regularly considers the relative merits of alternative sources of capital and is confident that this is an appropriate funding option at this time."

 

Commenting upon this transaction Nigel Hanbury, the Company's Chief Executive, said:

 

"Current market conditions continue to present the Company with attractive investment opportunities which require funding. We are delighted to have been able to successfully conclude this transaction which provides the Company with a modest war chest with which we can continue to progress acquisition opportunities. The reinsurance terms provide a profit commission in good underwriting years and a reduced risk exposure in disappointing underwriting years in a spectrum that is both equitable and commercially attractive. Its annually renewable feature provides Hampden Underwriting with certainty for 2013 as well as the appropriate opportunity to review the arrangement from time to time."

 

 

 

For further information please contact:

Hampden Underwriting

 

Nigel Hanbury

nigel.hanbury@hampdenplc.com

Smith & Williamson Corporate Finance

 

David Jones

020 7131 4000

 

Additional information on the reinsurance arrangements

The Company has entered a reinsurance agreement with Hampden Insurance PCC (Guernsey) Limited - Cell 6 ("Cell 6"), a newly-formed special purpose vehicle. On a back-to-back basis, Cell 6 has reinsured the reinsurance risk with Bermudan reinsurer, XL Re Ltd ("XL"), part of global NYSE-quoted insurer XL Group plc.

 

The key terms of the arrangements are as follows:

- XL will take on via Cell 6 the risks and rewards of 50% of the Company's existing 2013 underwriting activities (although the activities themselves and the underwriting capacity will remain the Company's);

- XL will provide a letter of credit to Lloyd's in an amount of £4.1m (approximately 50% of the Company's existing funds at Lloyd's ("FAL"), enabling an equivalent amount to be released from FAL to the Company;

- XL will pay a profit commission of between 10% and 20% of profits from the business ceded to the Company (via Cell 6) depending on the results of the relevant insurance years of account;

- XL will pay a fee to Cell 6 of 1.5% per year of account of the value of the letter of credit provided to Lloyd's and Cell 6 will pay this on to the Company, less the Company's share of Cell 6's management fees, costs and expenses which is estimated to be approximately £12,500 per annum; and

- the reinsurance arrangements apply to the Company's 2013 year of account and are renewable annually thereafter.

 

Cell 6 is ultimately 51% owned by Nigel Hanbury (a director and 14.8% shareholder in the Company) and 49% by Hampden Capital plc (a 11.9% shareholder in the Company). Nigel Hanbury and a number of Lloyd's underwriting entities ultimately owned by him and his family have entered reinsurance agreements with Cell 6 on a pari passu basis. The terms of the transaction have been approved by the independent members of the Company's board of directors.

 

 

About Hampden Underwriting plc

Hampden Underwriting plc has been incorporated primarily to provide a limited liability direct investment into the Lloyd's insurance market. Hampden Underwriting plc is quoted on the London Stock Exchange's AIM market (ticker: HUW). For further information please visit www.hampdenplc.com.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUNARROBABUAR
Date   Source Headline
21st Nov 20177:00 amRNSAcquisition of Chapman Underwriting Limited
29th Sep 20177:00 amRNSHalf-year Report
26th Sep 20177:00 amRNSAcquisition of Inversanda LLP
16th Aug 20177:00 amRNSDirector/PDMR Shareholding
11th Aug 20177:00 amRNSQuarterly Syndicate Mid Point Forecasts
29th Jun 20174:18 pmRNSResult of AGM and Directorate Change
9th Jun 20177:00 amRNSAcquisition of Nottus No 51 Limited
30th May 20177:00 amRNSFinal Results
23rd May 20177:00 amRNSQuarterly Syndicate Mid Point Forecasts
4th Apr 20177:00 amRNSAcquisition of Charmac
15th Mar 20177:00 amRNSQuarterly Syndicate Forecasts and Capacity Update
26th Jan 20177:00 amRNSAcquisition of Pooks
9th Jan 20174:34 pmRNSResult of General Meeting
22nd Dec 20167:00 amRNSProposed acquisition of Pooks Limited and GM
5th Dec 20167:01 amRNSUnderwriting Capacity
5th Dec 20167:00 amRNSAcquisition
29th Nov 20167:00 amRNSQuarterly Syndicate Forecasts
1st Nov 20162:56 pmRNSHolding(s) in Company
27th Oct 20161:22 pmRNSResults of GM and of Open Offer and TVR
10th Oct 201610:50 amRNSPosting of circular
6th Oct 20163:36 pmRNSHolding(s) in Company
30th Sep 20162:55 pmRNSResult of Placing and Open Offer Timetable
30th Sep 20167:01 amRNSProposed Placing and Open Offer
30th Sep 20167:00 amRNSHalf-year Report
25th Aug 201610:55 amRNSSyndicate Forecasts
3rd Aug 20164:29 pmRNSTotal Voting Rights
18th Jul 20165:14 pmRNSHolding(s) in Company
6th Jul 20165:30 pmRNSIssue of Equity
6th Jul 20165:30 pmRNSDirector/PDMR Shareholding
29th Jun 20169:35 amRNSResult of AGM
17th Jun 20167:00 amRNSScrip Dividend Reference Price
7th Jun 20165:38 pmRNSHolding(s) in Company
7th Jun 20167:00 amRNSSyndicate Forecasts
1st Jun 20165:41 pmRNSFinal Results - Replacement
31st May 20167:00 amRNSAppointment of Nominated Adviser and Broker
31st May 20167:00 amRNSFinal Results
31st May 20167:00 amRNSAcquisition
11th Apr 20167:00 amRNSDirectorate Change
23rd Mar 20164:39 pmRNSChange of Registered Office
22nd Mar 20167:00 amRNSSyndicate Forecasts
17th Feb 20165:14 pmRNSDirector/PDMR Shareholding
22nd Jan 20167:00 amRNSAcquisition
3rd Dec 201511:34 amRNSSyndicate Forecasts
30th Sep 201510:47 amRNSTotal Voting Rights
25th Sep 20157:00 amRNSHalf Yearly Report
28th Aug 20158:19 amRNSAcquisition
24th Aug 20157:00 amRNSSyndicate Forecasts
3rd Aug 20157:00 amRNSAcquisition
15th Jul 20157:00 amRNSAcquisitions
3rd Jul 20151:32 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.